Consists of dexamethasone, neomycin sulfate, thiabendazole solution
Pregnancy of Dexamethasone (Tresaderm) in details
Dexamethasone (Tresaderm) crosses the placenta (Brownfoot 2013); and is partially metabolized by placental enzymes to an inactive metabolite (Murphy 2007). Some studies have shown an association between first trimester systemic corticosteroid use and oral clefts or decreased birth weight; however, information is conflicting and may be influenced by maternal dose/indication for use (Lunghi 2010; Park-Wyllie 2000; Pradat 2003). Hypoadrenalism may occur in newborns following maternal use of corticosteroids during pregnancy; monitor.
Because antenatal corticosteroid administration may reduce the incidence of intraventricular hemorrhage, necrotizing enterocolitis, neonatal mortality, and respiratory distress syndrome, the injection is often used for antenatal fetal lung maturation in patients with preterm premature rupture of membranes or preterm labor who are at risk of preterm delivery (most data is available for betamethasone). A single course of corticosteroids is recommended for women between 24 and 34 weeks' gestation who are at risk of delivering within 7 days, including those with ruptured membranes or multiple gestations. A single course of corticosteroids may be considered for women beginning at 23 weeks' gestation, who are at risk of delivering within 7 days, in consultation with the family. In addition, a single course of corticosteroids may be given to women between 34 0/7 weeks and 36 6/7 weeks who are at risk of preterm delivery within 7 days and who have not previously received corticosteroids; use of concomitant tocolytics is not currently recommended and administration of late preterm corticosteroids has not been evaluated in women with intrauterine infection, multiple gestations, pregestational diabetes, or women who delivered previously by cesarean section at term. Multiple repeat courses are not recommended. However, in women with pregnancies less than 34 weeks' gestation at risk for delivery within 7 days and who had a course of antenatal corticosteroids >14 days prior, a single repeat course may be considered; use of a repeat course in women with premature rupture of membranes is controversial (ACOG 171 2016; ACOG 713 2017; ACOG 188 2018).
When systemic corticosteroids are needed in pregnancy, it is generally recommended to use the lowest effective dose for the shortest duration of time, avoiding high doses during the first trimester (Leachman 2006; Lunghi 2010; Makol 2011; Østensen 2009). Dexamethasone (Tresaderm) should not be used to treat primary adrenal insufficiency or congenital adrenal hyperplasia in pregnant women (ES [Bornstein 2016]; ES [Speiser 2018]).
Dexamethasone (Tresaderm) breastfeeding
Use is not recommended and a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Yes; however, it is not known whether intravitreal administration could result in sufficient systemic absorption to produce detectable quantities in human milk. Comments: The effects in the nursing infant are unknown.
See references
References for pregnancy information
- "Product Information. Decadron Ocumeter (Dexamethasone (Tresaderm))." Merck & Co, Inc, West Point, PA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Ozurdex (Dexamethasone (Tresaderm))." Allergan Inc, Irvine, CA.
References for breastfeeding information
- "Product Information. Decadron Ocumeter (Dexamethasone (Tresaderm))." Merck & Co, Inc, West Point, PA.
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Ozurdex (Dexamethasone (Tresaderm))." Allergan Inc, Irvine, CA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Pregnancy of Neomycin sulfate (Tresaderm) in details
Neomycin sulfate (Tresaderm) has been assigned to pregnancy category D by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy; however, other aminoglycoside antibiotics cross the placenta. Streptomycin use in pregnancy has been associated with irreversible bilateral deafness in children. Serious fetal side effects have not been reported with other aminoglycosides. Patients should be warned of potential hazards to the fetus if they if take Neomycin sulfate (Tresaderm) during pregnancy or become pregnant while taking this drug.
See references
Neomycin sulfate (Tresaderm) breastfeeding
There are no data on the excretion of Neomycin sulfate (Tresaderm) into human milk. Other aminoglycosides are excreted into human milk. The manufacturer recommends that due to the potential for adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Neomycin sulfate (Tresaderm) was excreted into cow milk after intramuscular injection.
See references
References for pregnancy information
- "Product Information. Neomycin sulfate (Tresaderm)" Pharma-Tek, Huntington, NY.
References for breastfeeding information
- "Product Information. Neomycin sulfate (Tresaderm)" Pharma-Tek, Huntington, NY.
Pregnancy of Thiabendazole solution (Tresaderm) in details
Thiabendazole solution (Tresaderm) has been assigned to pregnancy category C by the FDA. Some animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancies. Thiabendazole solution (Tresaderm) should only be given during pregnancy when there is evidence of clinical disease and benefit outweighs risk.
See references
Thiabendazole solution (Tresaderm) breastfeeding
There are no data on the excretion of Thiabendazole solution (Tresaderm) into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
See references
References for pregnancy information
- "Product Information. Mintezol (Thiabendazole solution (Tresaderm))." Merck & Co, Inc, West Point, PA.
References for breastfeeding information
- "Product Information. Mintezol (Thiabendazole solution (Tresaderm))." Merck & Co, Inc, West Point, PA.
References
- DailyMed. "THIABENDAZOLE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "DEXAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
